Log in
/
Register
Home
Overview
Upload / Manage Data
Browse / Search Studies
Analyze Studies
Tutorials
FAQ
Data Repository
Overview
Upload / Manage Studies
Browse / Search Studies
Analyze Studies
Data Sharing Policy
Tutorials
FAQ
Databases
Overview
Metabolite Database
Human Metabolome Gene/Protein Database (MGP)
RefMet: Reference List of Metabolite Names
External Metabolomics Databases (Links)
Protocols
Overview
General Protocols
Study-specific Protocols
Tools
Overview
Load and analyze your own dataset
Analyze Studies
MS Searches
Structure drawing
REST Service
External Tools (Links)
About
Overview
Publishing Partners
How to Cite
How to Link
Terms of Use
Personnel
Contact
Sitemap
Search
Keyword Search
Advanced Searches
Return to Statistics Toolbox
Correlation analysis for Study ST000196
Nodes mapped to fold-change between 2 conditions
Select one or more experimental factors for Groups 1 and 2. The members of each group should be DIFFERENT.
Group1
Experimental factor
Group2
Recovery:five week recovery | Gender:female | Treatment:Cefoperazone treated (3)
Recovery:five week recovery | Gender:male | Treatment:Cefoperazone treated (4)
Recovery:four week recovery | Gender:female | Treatment:Cefoperazone treated (4)
Recovery:four week recovery | Gender:male | Treatment:Cefoperazone treated (3)
Recovery:na | Gender:female | Treatment:No antibiotics (6)
Recovery:na | Gender:male | Treatment:No antibiotics (6)
Recovery:no recovery | Gender:female | Treatment:Cefoperazone treated (5)
Recovery:no recovery | Gender:female | Treatment:IP clindamycin (5)
Recovery:no recovery | Gender:female | Treatment:Kanamycin treated (6)
Recovery:no recovery | Gender:female | Treatment:Metronidazole treated (5)
Recovery:no recovery | Gender:female | Treatment:Vancomycin treated (6)
Recovery:no recovery | Gender:male | Treatment:Cefoperazone treated (5)
Recovery:no recovery | Gender:male | Treatment:IP clindamycin (6)
Recovery:no recovery | Gender:male | Treatment:Kanamycin treated (4)
Recovery:no recovery | Gender:male | Treatment:Metronidazole treated (6)
Recovery:no recovery | Gender:male | Treatment:Vancomycin treated (6)
Recovery:one week recovery | Gender:female | Treatment:Cefoperazone treated (7)
Recovery:one week recovery | Gender:male | Treatment:Cefoperazone treated (5)
Recovery:six week recovery | Gender:female | Treatment:Cefoperazone treated (4)
Recovery:six week recovery | Gender:female | Treatment:Cefoperazone treated IP clindamycin (6)
Recovery:six week recovery | Gender:male | Treatment:Cefoperazone treated (3)
Recovery:six week recovery | Gender:male | Treatment:Cefoperazone treated IP clindamycin (6)
Recovery:three week recovery | Gender:female | Treatment:Cefoperazone treated (5)
Recovery:three week recovery | Gender:male | Treatment:Cefoperazone treated (7)
Recovery:two week recovery | Gender:female | Treatment:Cefoperazone treated (6)
Recovery:two week recovery | Gender:male | Treatment:Cefoperazone treated (6)
Analysis:
ESI negative ion mode
Combine data for all analyses?:
Metabolomics Workbench
Terms of use
Site map
Contact